Healthcare Solutions International
About solutions contact

 

 

 


Stem Cell Controversy

Tristem's Non-controversial Source of Stem Cells

Stem Cell Therapy Procedure

Therapy Side Effects

Pre Therapy Testing

Regulatory Approvals

Every Procedure Element Approved Individually

Affordable Treatment

Patients Treated To-Date

How & Where to Obtain Stem Cell Therapy

Travel & Accommodation Logistics



Stem Cell Therapy

Patients Treated To-Date
The total number of patients that have been treated using Retrodifferentiated Stem Cell Therapy since March 1, 2005 are as follow: 

Beta Thalassaemia Major
We treated 28 patients in Beta Thalassaemia Major who required between 2 and 7 blood transfusions in a 2 month period with iron overload measured by Ferritin ranging from 1250 to 11,300.  90 days following the treatment their blood transfusion requirements fell to between 1 and 3 transfusions.  Their serum Ferritin levels fell to normal levels WITHOUT the use of any chelating agent such as Desferal or Feriprox.  Their distended stomachs reduced in size indicating organ repair and normalization.  Thalassaemia Major is a genetic disease in which the patient's red blood cells break down.  The only treatment known is to transfuse the patients with cross matched blood.  Transfusion may lead to the patient getting viruses in unscreened blood and additional iron from the donor.  This iron overload is what eventually kills the patients.  Average life of patients is between 7-10 years. 

Thalassaemia Intermedia
This is milder form of Thalassaemia Major.  The patient has recovered without requiring more than one transfusion in a 10 month period.  The patient was sickly and bed ridden every two weeks due to weakness.  10 months later, he has gained weight and does not require any transfusion or chelating agents of any kind. 

Sickle Cell Anaemia
This is milder form of Thalassaemia.  The patient has recovered requiring only one transfusion in a 7 month period.  The patient was sickly and tired every two-three weeks due to weakness.  In this 7 month period, he has gained weight and does not require any transfusion or chelating agents of any kind. 

Muscular Dystrophy
We have treated two patients.  Both had this debilitating disease with a very poor prognosis with eventual death.  Their condition improved substantially as measured by his levels of CPK, Aldolaise and LDH, all enzymes secreted by damaged muscles.  This process of muscle damage has now been stopped.  They are both able to walk better and have better control of their muscles allowing him to complete daily chores much easier and more normally. 

Type I Diabetes
We have completed treating 2 patients.  The results have been spectacular.  The patients in this disease require regular use of insulin as their pancreas are no longer synthesizing insulin.  The patients were on very high dosages of insulin every day.  Within 4 weeks the patients are synthesizing their own insulin!!!!!!  This is medically impossible.  Their Glysemic control as measured by HbA1C is now at normal levels in a period of 8 weeks.  Once again, this is not possible in this time frame. 

Type II Diabetes
We have completed treating 1 patients, male aged 54, Diabetic for the past 18 years.  The results have been even more spectacular.  The patient in this disease require regular use of glucofage tablets and eventually insulin as their pancreas are no longer synthesizing insulin.  The patient was on 40 units of insulin every day.  Despite this level of insulin intake, the patient had fasting sugar levels of 180-210 and random sugar levels of 280-380.  C-peptide was negligible (<0.5%) and HbA1C was 10.4.  Within 2 weeks the patient started synthesizing his own insulin!  Once again, this is medically impossible.  Their Glysemic control as measured by HbA1C is now coming towards normal.

Motor Neuron Disease (ALS)
We treated 5 patient with this debilitating disease who had approximately 2 years to live (based on disease survival averages).  Their speech was slurred, they could not walk unassisted on both sides, two had their necks hanging on their chest and could not sleep or yawn properly thereby not allowing them to sleep properly.  In all cases the patients’ voluntary breathing volume was not present, i.e. they failed the Pulmunary Function Test (PFT).  3 weeks following this procedure, 3 out of 4 patient's voices became much clearer, ¾ can now walk over 250 m assisted on one side only whereas they could not do more than 10m previously.  On the second day, one patient could yawn without locking his jaw and he had his fiscillations reduced in amplitude.  His body stiffness is down by over 90% (according to him) as he can now sleep better.  Two patients had their neck hanging on their chest.  Now they can hold their necks up completely / normally without any assistance.  In all cases, the patients’ breathing volume as measured by PFT has significantly increased.   

Spinal Cord Injury
We have treated 2 patients.  The first was a gun shot wound victim completely paralyzed from the neck down.  Within 3 days, the patient could sit on his own and had strength/feeling in his upper body/arms.  8 weeks later he can now move his toes voluntarily whereas no motion was possible before the procedure.  He claims now to be getting some feeling in his bowels where there was none before. 

The second patient was a motor cycle accident victim who had no feeling / motion below his navel.  He now has partial feeling in his lower limbs compared to none before.  He can actually stand when assisted or against a wall for much longer than before. 

Parkinson's Disease
We have treated 3 patients.  The patients have advised us that their symptoms have greatly reduced (shaking and tension in the limbs).  The patients could only walk assisted on both sides prior to the procedure.  Post procedure, the patients have improved balance and unassisted walking abilities with improved stamina. 

Aplastic Anaemia Patients
4 patients suffering from Aplastic Anaemia were treated in India in 2004.  These patients had between 4 and 8 weeks to live and all of them were blood product transfusion dependant.  21 months after the procedure, 3 of them are living normal lives.  One patient died due to causes unrelated to this treatment.  Specifically, the patient died of Pneumonia as a result of traveling to his village against the advice of his doctors. 

Psoriasis
One of the patients treated for Severe Aplastic Anaemia suffered from severe psoriasis.  Following the treatment, within 7 days the psoriasis disappeared completely after a lapse of over 21 months, has not recurred. 

Hepatitis C
2 patients that tested positive for Hepatitis C and had viral loads ranging from 17,500 IU/ml to 395,000 IU/ml as tested via PCR had their viral loads decreased to zero IU/ml and 96,900 IU/ml in a period of 6.5 weeks after one treatment.  These patients suffer from Beta Thalassaemia major.